Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-04-05 3:59 pm Purchase | 13G | SANGAMO THERAPEUTICS INC SGMO | WASATCH ADVISORS LP | 24,894,229 11.9% | 12,496,305 (+100.79%) | View |
| 2024-02-13 5:13 pm Sale | 13G | SANGAMO THERAPEUTICS INC SGMO | VANGUARD GROUP INC | 12,598,994 7.1% | -1,446,615 (-10.30%) | View |
| 2024-02-12 7:11 pm Sale | 13G | SANGAMO THERAPEUTICS INC SGMO | BIOGEN INC. BIIB | 14,652,466 8.26% | -9,767,691 (-40.00%) | View |
| 2024-02-09 12:17 pm Sale | 13G | SANGAMO THERAPEUTICS INC SGMO | WASATCH ADVISORS LP | 12,397,924 7% | -5,588,857 (-31.07%) | View |
| 2024-01-26 11:49 am Sale | 13G | SANGAMO THERAPEUTICS INC SGMO | BlackRock Inc. BLK | 14,095,865 7.9% | -1,263,576 (-8.23%) | View |
| 2024-01-22 12:18 pm Sale | 13G | SANGAMO THERAPEUTICS INC SGMO | STATE STREET CORP STT | 2,708,368 1.53% | -7,080,516 (-72.33%) | View |
| 2023-10-10 3:09 pm Purchase | 13G | SANGAMO THERAPEUTICS INC SGMO | WASATCH ADVISORS LP | 17,986,781 10.16% | 5,336,027 (+42.18%) | View |
| 2023-02-09 4:21 pm Purchase | 13G | SANGAMO THERAPEUTICS INC SGMO | WASATCH ADVISORS LP | 12,650,754 7.7% | 1,689,772 (+15.42%) | View |
| 2023-02-09 11:32 am Purchase | 13G | SANGAMO THERAPEUTICS INC SGMO | VANGUARD GROUP INC | 14,045,609 8.57% | 4,705,054 (+50.37%) | View |
| 2023-02-07 1:49 pm Purchase | 13G | SANGAMO THERAPEUTICS INC SGMO | STATE STREET CORP STT | 9,788,884 5.97% | 4,974,258 (+103.32%) | View |
| 2023-01-24 1:56 pm Purchase | 13G | SANGAMO THERAPEUTICS INC SGMO | BlackRock Inc. BLK | 15,359,441 9.4% | 3,696,561 (+31.70%) | View |
| 2022-02-10 5:42 pm Purchase | 13G | SANGAMO THERAPEUTICS INC SGMO | WASATCH ADVISORS LP | 10,960,982 7.5% | 888,601 (+8.82%) | View |
| 2022-02-10 08:37 am Purchase | 13G | SANGAMO THERAPEUTICS INC SGMO | VANGUARD GROUP INC | 9,340,555 6.41% | 886,897 (+10.49%) | View |
| 2022-02-01 5:08 pm Purchase | 13G | SANGAMO THERAPEUTICS INC SGMO | BlackRock Inc. BLK | 11,662,880 8% | 2,096,465 (+21.91%) | View |
| 2021-02-11 2:09 pm Purchase | 13G | SANGAMO THERAPEUTICS INC SGMO | WASATCH ADVISORS LP | 10,072,381 7.1% | 2,585,364 (+34.53%) | View |
| 2021-02-10 11:52 am Sale | 13G | SANGAMO THERAPEUTICS INC SGMO | VANGUARD GROUP INC | 8,453,658 5.98% | -34,846 (-0.41%) | View |
| 2021-02-04 11:42 am Sale | 13G | SANGAMO THERAPEUTICS INC SGMO | WELLINGTON MANAGEMENT GROUP LLP | 229 0% | -7,840,453 (-100.00%) | View |
| 2021-02-01 08:23 am Purchase | 13G | SANGAMO THERAPEUTICS INC SGMO | BlackRock Inc. BLK | 9,566,415 6.8% | 32,144 (+0.34%) | View |
| 2020-04-17 4:13 pm Purchase | 13G | SANGAMO THERAPEUTICS INC SGMO | BIOGEN INC. BIIB | 24,420,157 17.37% | 24,420,157 (New Position) | View |
| 2020-02-13 3:24 pm Sale | 13G | SANGAMO THERAPEUTICS INC SGMO | STATE STREET CORP STT | 4,814,626 4.15% | -1,095,526 (-18.54%) | View |